Science Corporation implants PRIMA chip in its first patient with Stargardt disease

TechCrunch reports Science Corporation implanted its PRIMA chip in its first patient with Stargardt disease, which gradually destroys central vision. The company says he received it in May during a trial at Sydney Eye Hospital and saw a letter in his first rehabilitation session, then read a word in his second. Camera-equipped glasses transmit a view to the chip, which CEO Max Hodak says provides a narrow, black-and-white patch of central vision.